MSI Financial Services’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$6K Sell
300
-194
-39% -$3.77K ﹤0.01% 3039
2016
Q3
$9K Buy
494
+194
+65% +$3.52K ﹤0.01% 2833
2016
Q2
$5K Hold
300
﹤0.01% 3119
2016
Q1
$4K Hold
300
﹤0.01% 3229
2015
Q4
$4K Hold
300
﹤0.01% 3154
2015
Q3
$4K Hold
300
﹤0.01% 2475
2015
Q2
$5K Hold
300
﹤0.01% 2412
2015
Q1
$4K Hold
300
﹤0.01% 2503
2014
Q4
$3K Hold
300
﹤0.01% 2275
2014
Q3
$3K Buy
+300
New +$3.13K ﹤0.01% 2253

Other funds holding AMPH

MSI Financial Services's AMPH Position: Q4 2016 in Review

MSI Financial Services reduced its Amphastar Pharmaceuticals (AMPH) stake by 39% in Q4 2016, selling an estimated $3.77K and leaving 300 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #3039.

MSI Financial Services first reported a position in AMPH in Q3 2014 and has held it in 10 quarters since. The position peaked at $9K in Q3 2016. 138 funds tracked by Wall St. Rank hold AMPH as of Q4 2016.

  • MSI Financial Services held 300 shares of Amphastar Pharmaceuticals worth $6K as of Q4 2016.
  • MSI Financial Services sold 194 Amphastar Pharmaceuticals shares in Q4 2016, an estimated $3.77K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3039 holding.
  • MSI Financial Services first reported a position in Amphastar Pharmaceuticals in Q3 2014 and has held it in 10 quarters since.
  • MSI Financial Services's Amphastar Pharmaceuticals position peaked at $9K in Q3 2016.
  • 138 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.